Tobramycin
| PK/PD Index | 24-hr AUC/MIC |
|---|---|
| Pharmaceutical Preparations | Injection 0.3% oph ointment 0.3% eye drops Inhalation |
| Food Rec (PO Drugs) <sup>1</sup> | - |
| Oral Absorption (%) | - |
| Tmax (hr) | - |
| Peak Serum Conc (µg/mL) <sup>2</sup> | 4-6 (1.7 mg/kg IV, SD) |
| Peak Urine Conc (µg/mL) | No data |
| Protein Binding (%) | 0-10 |
| Volume of Distribution (Vd) <sup>3</sup> | 0.26 L/kg |
| Avg Serum T½ (hr) <sup>4</sup> | 2-3 |
| Elimination | Renal |
| Bile Penetration (%) <sup>5</sup> | 10-60 |
| CSF/blood (%) <sup>6</sup> | 0-30 |
| Therapeutic Levels in CSF <sup>7</sup> | No |
| AUC (µg*hr/mL) <sup>8</sup> | 70-100 (7 mg/kg, 0-inf) |